BR112012011017A2 - processos e composições para tratamento rápido de otite externa - Google Patents
processos e composições para tratamento rápido de otite externaInfo
- Publication number
- BR112012011017A2 BR112012011017A2 BR112012011017A BR112012011017A BR112012011017A2 BR 112012011017 A2 BR112012011017 A2 BR 112012011017A2 BR 112012011017 A BR112012011017 A BR 112012011017A BR 112012011017 A BR112012011017 A BR 112012011017A BR 112012011017 A2 BR112012011017 A2 BR 112012011017A2
- Authority
- BR
- Brazil
- Prior art keywords
- compositions
- processes
- otitis externa
- treatment
- rapid treatment
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 5
- 238000000034 method Methods 0.000 title abstract 4
- 206010033072 otitis externa Diseases 0.000 title abstract 4
- 150000002632 lipids Chemical class 0.000 abstract 2
- 206010061217 Infestation Diseases 0.000 abstract 1
- 206010061218 Inflammation Diseases 0.000 abstract 1
- 239000013543 active substance Substances 0.000 abstract 1
- 239000000853 adhesive Substances 0.000 abstract 1
- 230000001070 adhesive effect Effects 0.000 abstract 1
- 229920002678 cellulose Polymers 0.000 abstract 1
- 235000010980 cellulose Nutrition 0.000 abstract 1
- 210000000883 ear external Anatomy 0.000 abstract 1
- 230000002538 fungal effect Effects 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- 239000002502 liposome Substances 0.000 abstract 1
- 230000036407 pain Effects 0.000 abstract 1
- 230000003071 parasitic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0046—Ear
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Dispersion Chemistry (AREA)
- Botany (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Anesthesiology (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
processos e composições para tratamento rápido de otite externa. a presente invenção refere-se a processos para o tratamento e para a prevenção de otite externa com um período de tratamento que consiste apenas em uma dose única. os processos são praticados através da administração tópica de composições que possuem um carreador lipídico, tais como lipossomos e lipídeos não vesiculares, no canal do ouvido externo. tais composições não possuem celuloses que aumentam a viscosidade ou adesivos, e preferencialmente não estão na forma de um gel. os agentes ativos úteis para o tratamento de dor, inflamação, infestação fúngica ou parasita e/ou infecções no ouvido externo são coadministrados dentro ou com a composição.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US26030909P | 2009-11-11 | 2009-11-11 | |
PCT/US2010/056255 WO2011060083A1 (en) | 2009-11-11 | 2010-11-10 | Methods and compositions for rapid treatment of otitis externa |
Publications (1)
Publication Number | Publication Date |
---|---|
BR112012011017A2 true BR112012011017A2 (pt) | 2015-09-15 |
Family
ID=43992011
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112012011017A BR112012011017A2 (pt) | 2009-11-11 | 2010-11-10 | processos e composições para tratamento rápido de otite externa |
Country Status (28)
Country | Link |
---|---|
US (1) | US8927006B2 (pt) |
EP (1) | EP2498792B1 (pt) |
JP (2) | JP2013510861A (pt) |
KR (2) | KR20120116398A (pt) |
CN (1) | CN102612372B (pt) |
AU (1) | AU2010319538B2 (pt) |
BR (1) | BR112012011017A2 (pt) |
CA (1) | CA2780160C (pt) |
CL (1) | CL2012001227A1 (pt) |
CO (1) | CO6540004A2 (pt) |
DK (1) | DK2498792T3 (pt) |
EC (1) | ECSP12011967A (pt) |
ES (1) | ES2645200T3 (pt) |
HR (1) | HRP20171520T1 (pt) |
HU (1) | HUE034617T2 (pt) |
IL (1) | IL219483A (pt) |
LT (1) | LT2498792T (pt) |
MX (1) | MX2012005521A (pt) |
MY (1) | MY162687A (pt) |
NO (1) | NO2498792T3 (pt) |
NZ (1) | NZ599559A (pt) |
PL (1) | PL2498792T3 (pt) |
PT (1) | PT2498792T (pt) |
RU (1) | RU2680137C2 (pt) |
SI (1) | SI2498792T1 (pt) |
UA (1) | UA111147C2 (pt) |
WO (1) | WO2011060083A1 (pt) |
ZA (1) | ZA201203239B (pt) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2014036165A1 (en) * | 2012-08-29 | 2014-03-06 | Bayer Healthcare, Llc | Aqueous based compositions for treating otitis externa |
CN104337952A (zh) * | 2013-08-10 | 2015-02-11 | 李谊 | 一种中西医结合治疗爆震性耳聋的组合药物 |
CN104739768A (zh) * | 2013-12-27 | 2015-07-01 | 河南惠通天下生物工程有限公司 | 一种甲砜霉素纳米脂质体及其制备方法 |
EP3482744A1 (de) * | 2017-11-14 | 2019-05-15 | ProFem GmbH | Emulsionen zur topischen behandlung urogenitaler und dermaler infektionen |
ES2963980T3 (es) | 2017-11-14 | 2024-04-03 | Profem Gmbh | Emulsiones para el tratamiento tópico de infecciones dérmicas y mucosas |
CA3155131A1 (en) | 2019-09-23 | 2021-04-01 | Dds Research Inc. | Lipid vesicle compositions with penetration enhancing agents |
CN114450010A (zh) * | 2019-10-11 | 2022-05-06 | 皮埃蒙特动物健康公司 | 耳用制剂、方法和装置 |
CN113876658B (zh) * | 2021-11-01 | 2023-10-20 | 仙乐健康科技股份有限公司 | 水包油型乳液组合物及其制备方法 |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HUT75459A (en) * | 1994-02-04 | 1997-05-28 | Scotia Lipidteknik Ab | Carrier compositions comprising lipid-solvent bilayer |
WO1996011003A1 (en) * | 1994-10-10 | 1996-04-18 | Novartis Ag | Ophthalmic and aural compositions containing diclofenac potassium |
DK0782448T3 (da) * | 1995-06-06 | 2002-07-08 | Bayer Ag | Ikke-irriterende, ikke-sensibiliserende, ikke-ototoksiske antibakterielle ørepræparater |
IT1295369B1 (it) | 1997-10-21 | 1999-05-12 | Fatro Spa | Composizione a base di tiamfenicolo e diclofenac |
US6433024B1 (en) * | 2000-05-08 | 2002-08-13 | Karl F. Popp | Topical anti-acne composition |
AUPR798901A0 (en) * | 2001-09-28 | 2001-10-25 | Medvet Science Pty. Ltd. | Spheroidal hdl particles with a defined phospholipid composition |
US20080206161A1 (en) * | 2002-10-25 | 2008-08-28 | Dov Tamarkin | Quiescent foamable compositions, steroids, kits and uses thereof |
US20050013854A1 (en) * | 2003-04-09 | 2005-01-20 | Mannino Raphael J. | Novel encochleation methods, cochleates and methods of use |
RU2319508C2 (ru) | 2003-07-31 | 2008-03-20 | ФАРМАЦИЯ ЭНД АПДЖОН КОМПАНИ ЭлЭлСи | Диспергируемый препарат противовоспалительного агента |
US20050159369A1 (en) | 2003-08-20 | 2005-07-21 | Qtm Llc | Method of treatment of otitis externa |
US20070078116A1 (en) * | 2003-08-20 | 2007-04-05 | Fairfield Clinical Trials, Llc | Method of treatment of otitis externa |
US20070054844A1 (en) | 2003-08-20 | 2007-03-08 | Fairfield Clinical Trials, Llc | Method for treating otitis externa |
MX2007002462A (es) | 2004-09-03 | 2007-10-10 | Piedmont Pharmaceuticals Llc | Metodo para el tratamiento de transmembrana y prevencion de la otitis media. |
JP2008533048A (ja) * | 2005-03-10 | 2008-08-21 | スリーエム イノベイティブ プロパティズ カンパニー | 耳の感染症の治療方法 |
US20090082337A1 (en) | 2007-09-21 | 2009-03-26 | Srini Venkastesh | Compositions Comprising Quinolone and Methods for Treating or Controlling Infections |
US20090111780A1 (en) * | 2007-10-31 | 2009-04-30 | Everett Laboratories, Inc. | Compositions and methods for treatment of ear canal infection and inflammation |
-
2010
- 2010-10-11 UA UAA201207023A patent/UA111147C2/uk unknown
- 2010-11-10 JP JP2012538954A patent/JP2013510861A/ja active Pending
- 2010-11-10 WO PCT/US2010/056255 patent/WO2011060083A1/en active Application Filing
- 2010-11-10 AU AU2010319538A patent/AU2010319538B2/en active Active
- 2010-11-10 PL PL10830669T patent/PL2498792T3/pl unknown
- 2010-11-10 KR KR1020127013348A patent/KR20120116398A/ko active Application Filing
- 2010-11-10 HU HUE10830669A patent/HUE034617T2/en unknown
- 2010-11-10 SI SI201031550T patent/SI2498792T1/sl unknown
- 2010-11-10 CA CA2780160A patent/CA2780160C/en active Active
- 2010-11-10 US US12/943,810 patent/US8927006B2/en active Active
- 2010-11-10 PT PT108306697T patent/PT2498792T/pt unknown
- 2010-11-10 MY MYPI2012001989A patent/MY162687A/en unknown
- 2010-11-10 RU RU2012124067A patent/RU2680137C2/ru active
- 2010-11-10 LT LTEP10830669.7T patent/LT2498792T/lt unknown
- 2010-11-10 ES ES10830669.7T patent/ES2645200T3/es active Active
- 2010-11-10 BR BR112012011017A patent/BR112012011017A2/pt not_active Application Discontinuation
- 2010-11-10 NZ NZ599559A patent/NZ599559A/en unknown
- 2010-11-10 EP EP10830669.7A patent/EP2498792B1/en active Active
- 2010-11-10 CN CN201080051245.7A patent/CN102612372B/zh active Active
- 2010-11-10 MX MX2012005521A patent/MX2012005521A/es active IP Right Grant
- 2010-11-10 KR KR1020177023631A patent/KR101901083B1/ko active IP Right Grant
- 2010-11-10 DK DK10830669.7T patent/DK2498792T3/da active
- 2010-11-10 NO NO10830669A patent/NO2498792T3/no unknown
-
2012
- 2012-04-30 IL IL219483A patent/IL219483A/en active IP Right Grant
- 2012-05-04 ZA ZA2012/03239A patent/ZA201203239B/en unknown
- 2012-05-10 CL CL2012001227A patent/CL2012001227A1/es unknown
- 2012-06-01 CO CO12092192A patent/CO6540004A2/es unknown
- 2012-06-11 EC ECSP12011967 patent/ECSP12011967A/es unknown
-
2015
- 2015-11-13 JP JP2015222609A patent/JP6138891B2/ja active Active
-
2017
- 2017-10-10 HR HRP20171520TT patent/HRP20171520T1/hr unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112012011017A2 (pt) | processos e composições para tratamento rápido de otite externa | |
MY188960A (en) | Cyclic boronic acid ester derivatives and therapeutic uses thereof | |
MX2011009847A (es) | Agentes antihelminticos y su uso. | |
SG10201902429PA (en) | Combination therapy including an mdm2 inhibitor and one or more additional pharmaceutically active agents for the treatment of cancers | |
UA109991C2 (xx) | Карбаматні сполуки, їх отримання і застосування | |
DOP2012000225A (es) | Compuestos de pirrolo-pirimidina como inhibidores de cdk4/6 | |
MX340985B (es) | Compuestos de n-heteroarilo. | |
BR112012016879A2 (pt) | Derivados de fumarato de acido graxo e seus usos | |
BR112015014458A8 (pt) | compostos derivados de manose, seus intermediários, composição, uso e processos de preparação | |
BRPI1007379B8 (pt) | composições farmacêuticas para o tratamento ou prevenção de infecções orais por e. coli | |
BR112012021086A2 (pt) | composições farmacêuticas de composto espiro-oxindole para administração tópica e seu uso como agentes terapêuticos | |
EA201492290A1 (ru) | Составы и способы для вагинальной доставки антипрогестинов | |
BR112014018421A8 (pt) | Composições antimicrobianas compreendendo dgla, 15-ohepa e/ou 15-hetre e métodos de uso das mesmas | |
BR112014026058A2 (pt) | composições para tratamento tópico de infecções microbianas | |
BR112015019412A8 (pt) | inibidores de bace1, seus usos, e composição farmacêutica | |
BR112012005044A2 (pt) | composições que compreendem tramadol e celecoxib no tratamento de dor. | |
AR077372A1 (es) | Composiciones y metodos para tratar infecciones oftalmicas oticas o nasales | |
MX341220B (es) | Polisacarido de semillas de tamarindo para usarse en el tratamiento de infecciones microbianas. | |
BR112015013783A2 (pt) | quitina ou seus derivados para a prevenção e / ou tratamento de parasitoses | |
MX2011013869A (es) | Agentes antihelminticos y su uso. | |
MX342859B (es) | Polisacarido de las semillas de tamarindo para usarse en el tratamiento de enfermedades inflamatorias. | |
BR112015011693A2 (pt) | composições fibrinolíticas compreendendo bromelina e nattokinase para a prevenção e tratamento de estados flebotrombóticos | |
BR112022004777A2 (pt) | Composição de micela de estimulação imunológica | |
WO2011058245A8 (fr) | Nouveaux derives de mannopyranoside ayant une activite anticancereuse | |
MX2014011218A (es) | Uso de agentes tensoactivos anfotericos para la prevencion y tratamiento de biopeliculas vaginales patogenas en infecciones vaginales. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE AS 3A E 4A ANUIDADES. |
|
B08G | Application fees: restoration [chapter 8.7 patent gazette] | ||
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] |
Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS. |
|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
B07B | Technical examination (opinion): publication cancelled [chapter 7.2 patent gazette] | ||
B06T | Formal requirements before examination [chapter 6.20 patent gazette] | ||
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B09B | Patent application refused [chapter 9.2 patent gazette] | ||
B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL |